Jim Brown - Net Worth and Insider Trading

Jim Brown Net Worth

The estimated net worth of Jim Brown is at least $0 dollars as of 2024-04-19. Jim Brown is the PRESIDENT of Usana Health Sciences Inc and owns about 0 shares of Usana Health Sciences Inc (USNA) stock worth over $0. Details can be seen in Jim Brown's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jim Brown has not made any transactions after 2023-05-08 and currently still holds the listed stock(s).

Transaction Summary of Jim Brown

To

Jim Brown Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jim Brown owns 1 companies in total, including Usana Health Sciences Inc (USNA) .

Click here to see the complete history of Jim Brown’s form 4 insider trades.

Insider Ownership Summary of Jim Brown

Ticker Comapny Transaction Date Type of Owner
USNA Usana Health Sciences Inc 2023-05-08 Chief Production Officer

Jim Brown Latest Holdings Summary

Jim Brown currently owns a total of 1 stock. Jim Brown owns 0 shares of Usana Health Sciences Inc (USNA) as of May 8, 2023, with a value of $0.

Latest Holdings of Jim Brown

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
USNA Usana Health Sciences Inc 2023-05-08 0 43.47 0

Holding Weightings of Jim Brown


Jim Brown Form 4 Trading Tracker

According to the SEC Form 4 filings, Jim Brown has made a total of 5 transactions in Usana Health Sciences Inc (USNA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Usana Health Sciences Inc is the sale of 12,202 shares on May 8, 2023, which brought Jim Brown around $811,189.

Insider Trading History of Jim Brown

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jim Brown Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jim Brown Ownership Network

Ownership Network List of Jim Brown

No Data

Ownership Network Relation of Jim Brown


Jim Brown Owned Company Details

What does Usana Health Sciences Inc do?

Who are the key executives at Usana Health Sciences Inc?

Jim Brown is the Chief Production Officer of Usana Health Sciences Inc. Other key executives at Usana Health Sciences Inc include E.V.P. of Marketing Kevin Guest , Chief Information Officer Walter Noot , and CO & Man. Dir. of China Brent Neidig .

Usana Health Sciences Inc (USNA) Insider Trades Summary

Over the past 18 months, Jim Brown made no insider transaction in Usana Health Sciences Inc (USNA). Other recent insider transactions involving Usana Health Sciences Inc (USNA) include a net sale of 2,684 shares made by Gilbert A Fuller , a net sale of 12,042 shares made by David Mulham Mulham , and a net sale of 8,376 shares made by Brent Neidig .

In summary, during the past 3 months, insiders sold 35,940 shares of Usana Health Sciences Inc (USNA) in total and bought 0 shares, with a net sale of 35,940 shares. During the past 18 months, 102,003 shares of Usana Health Sciences Inc (USNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 102,003 shares.

Usana Health Sciences Inc (USNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Usana Health Sciences Inc Insider Transactions

No Available Data

Jim Brown Mailing Address

Above is the net worth, insider trading, and ownership report for Jim Brown. You might contact Jim Brown via mailing address: 3838 West Parkway Blvd., Salt Lake City Ut 84120.

Discussions on Jim Brown

No discussions yet.